Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer

Multiparametric MRI (mpMRI) has become an indispensable radiographic tool in diagnosing prostate cancer. However, mpMRI fails to visualize approximately 15% of clinically significant prostate cancer (csPCa). The molecular, cellular, and spatial underpinnings of such radiographic heterogeneity in csP...

Full description

Saved in:
Bibliographic Details
Published in:Clinical cancer research 2021-06, Vol.27 (12), p.3478-3490
Main Authors: Pachynski, Russell K, Kim, Eric H, Miheecheva, Natalia, Kotlov, Nikita, Ramachandran, Akshaya, Postovalova, Ekaterina, Galkin, Ilia, Svekolkin, Viktor, Lyu, Yang, Zou, Qiong, Cao, Dengfeng, Gaut, Joseph, Ippolito, Joseph E, Bagaev, Alexander, Bruttan, Maria, Gancharova, Olga, Nomie, Krystle, Tsiper, Maria, Andriole, Gerald L, Ataullakhanov, Ravshan, Hsieh, James J
Format: Article
Language:English
Subjects:
Artificial Intelligence
Ecosystem
Humans
Male
Multiparametric Magnetic Resonance Imaging
Prostatic Neoplasms - diagnostic imaging
Prostatic Neoplasms - genetics
Prostatic Neoplasms - surgery
Proteomics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Multiparametric MRI (mpMRI) has become an indispensable radiographic tool in diagnosing prostate cancer. However, mpMRI fails to visualize approximately 15% of clinically significant prostate cancer (csPCa). The molecular, cellular, and spatial underpinnings of such radiographic heterogeneity in csPCa are unclear. We examined tumor tissues from clinically matched patients with mpMRI-invisible and mpMRI-visible csPCa who underwent radical prostatectomy. Multiplex immunofluorescence single-cell spatial imaging and gene expression profiling were performed. Artificial intelligence-based analytic algorithms were developed to examine the tumor ecosystem and integrate with corresponding transcriptomics. More complex and compact epithelial tumor architectures were found in mpMRI-visible than in mpMRI-invisible prostate cancer tumors. In contrast, similar stromal patterns were detected between mpMRI-invisible prostate cancer and normal prostate tissues. Furthermore, quantification of immune cell composition and tumor-immune interactions demonstrated a lack of immune cell infiltration in the malignant but not in the adjacent nonmalignant tissue compartments, irrespective of mpMRI visibility. No significant difference in immune profiles was detected between mpMRI-visible and mpMRI-invisible prostate cancer within our patient cohort, whereas expression profiling identified a 24-gene stromal signature enriched in mpMRI-invisible prostate cancer. Prostate cancer with strong stromal signature exhibited a favorable survival outcome within The Cancer Genome Atlas prostate cancer cohort. Notably, five recurrences in the 8 mpMRI-visible patients with csPCa and no recurrence in the 8 clinically matched patients with mpMRI-invisible csPCa occurred during the 5-year follow-up post-prostatectomy. Our study identified distinct molecular, cellular, and structural characteristics associated with mpMRI-visible csPCa, whereas mpMRI-invisible tumors were similar to normal prostate tissue, likely contributing to mpMRI invisibility.
ISSN:1078-0432
1557-3265
DOI:10.1158/1078-0432.CCR-20-4217